Neurofibromatosis type 1 (NFI) is the commonest form of neurofibromatosis and has a frequency of about 1 in 3000 to 1 in 3500.192°Although the gene is almost 100% penetrant, the disease itself has extremely variable expressivity.20 About 50% ofindex cases and 30% ofall NFl cases are considered to be new mutations. The high mutation rate may be due in part to the large size of the gene and its transcript, or possibly to the presence of sequences within the gene highly susceptible to mutation.
Clinicalfeatures Particular clinical features are critical for establishing the diagnosis of NF1 in any individual, whereas a multitude of other features are commonly and variably present. The disease is defined using the clinical criteria outlined in Table  1 . Typically, NFl is associated with the formation of multiple tumour types in addition to the neurofibromas, including optic gliomas, neurofibrosarcomas, astrocytomas, meningiomas, ependymomas, and phaeochromocytomas. Individuals with NFI may also be at increased risk of developing other malignancies seen more commonly in the general population -for example, chronic myelogenous leukaemia of childhood, Wilms' tumour, and rhabdomyosarcoma. 2 22 Many of the tissues involved in either dysplasia or neoplasia are derived from the neural crest.
Skin hyperpigmentation. Multiple cafe au lait patches (CAL) are present in over 99% of individuals with NF1, and can range in size from a few millimetres to more than 50 cm in diameter (Fig 1) .23 They tend to be present at birth or develop within the first year of life. Larger areas of hyperpigmentation may be either a typical flat CAL or may outline an underlying plexiform neurofibroma. When the hyperpigmentation overlying a plexiform neurofibroma extends to the midline, it may signify underlying spinal cord involvement. Individuals with NFl may also have a diffuse skin hyperpigmentation or innumerable freckles. Freckling may be congenital, when it is usually seen in the axillary region, or acquired later in childhood, when it develops in the inguinal and other intertriginous zones, at points of friction, or diffusely over the entire body. In a large proportion of white adults with NFl, biopsies of CALs demonstrate a high 27 Individuals with NFl can display other ocular abnormalities. In the anterior segment these include prominent corneal, conjunctival, and ciliary nerves,28 congenital ectropion uveae,9 angle anomalies, posterior embryotoxon, buphthalmos, or later onset glaucoma30 especially in association with an ipsilateral plexiform neurofibroma of the eyelid, heterochromia iridis, iris mammillations,28 neurofibromas of conjunctival and ciliary nerves,3"3" and anterior subcapsular cataract.' In the posterior segment they include hamartomas of the optic disc,32 retina, and choroid,28 combined pigment epithelial and retinal hamartomas (although this may be more a feature of NF2),33-3s which are sometimes associated with retinal tear and detachment,35 retinal haemangioma,35 choroidal 'ovoid bodies' of neurofibromatosis,1 -637 and anterior visual pathway gliomas (see below), including gliomas of the optic disc. Choroidal naevi and melanoma,3' congenital hypertrophy of the retinal pigment epithelium, myelinated nerve fibres, and sectoral retinitis pigmentosa have also been described in association with NF1, although, given their prevalence in the general population, their appearance may be coincidental. Ocular adnexae may be affected by plexiform neurofibromas ofthe eyelid and orbit,4' other orbital tumours, and absence of part of the sphenoid wing, with resultant pulsating exophthalmos.
Optic pathway gliomas
Gliomas of the anterior visual pathway are well recognised in NFl123 [42] [43] [44] Although the frequency of this varies from 10-70% depending on the study, a retrospective analysis of reported cases45 and two recent prospective studies have shown the incidence of anterior pathway gliomas to be about 15% of NFl patients.42I However, in one study only 5% of NFl patients were symptomatic from their gliomas, irrespective of location in the optic nerve or chiasm.42 Bilateral optic nerve gliomas or 'multicentric' gliomas made up between 30% and 80% of optic pathway gliomas, depending on whether minor optic nerve thickening was included in the data analysis. 42 The recent use of magnetic resonance (MR) scanning demonstrates a higher incidence of subclinical lesions not detected on computed tomography (CT) scan, especially in the optic nerves. Only long term studies will demonstrate the significance of these lesions and their relation to the full spectrum of optic nerve gliomas.
Optic pathway gliomas can display features that are deemed to be diagnostic or highly suggestive of NFl. Bilateral optic nerve gliomas are felt to be pathognomonic of NFL.43 Tubular expansion of one or both optic nerves, often with lengthening and kinking ofthe optic nerve (see Fig  3A) , is highly characteristic ofNFl gliomas. The optic nerve glioma may sometimes extend to include the chiasm (see Fig  4) . CT, and now MR scans demonstrate double density tubular thickening of fusiform optic nerve gliomas seen in NFl (see Fig 3B) . On T2 weighted MR images, a zone of high intensity surrounds a central low density core, representing the optic nerve (see Figs 3A and 3B) .434" The high intensity area appears to correspond to the pathological finding of perineural arachnoidal gliomatosis.43 4441 This perineural pattern of arachnoidal proliferation, compared Although the first case description probably appeared as early as 1822,107 neurofibromatosis type 2 (NF2), formerly known as central neurofibromatosis, has been defined as an entity distinct from neurofibromatosis type 1 only in the last decade or so. Clinical'"'" and genetic evidence"0 have now confirmed this. Since this division, a clearer, but also continuously evolving, clinical picture of NF2 is emerging. NF2 is a much rarer disease than NFI, with a population incidence of 1 in 33000-40000."' About 50% of all cases"' 667 and 75% of index cases appear to represent new mutations (V M Riccardi, personal communication). The mutation rate is estimated to be 6 5x 10-6, lower than NFl."' Like NFl, the disease has an extremely high penetrance rate, over 95% in one study.'"'
The hallmark feature of NF2 is the presence of bilateral vestibular schwannomas ('acoustic neuromas'). However, according to NIH criteria,' the diagnosis can also be made if there is a first degree relative with NF2 and there is either a unilateral eighth nerve mass, or any two of the following: neurofibroma, menngioma, glioma, schwannoma, or juvenile posterior subcapsular (or capsular) lens opacity (see Table 2 ). The main features that distinguish NF2 from NFI are the presence of bilateral vestibular schwannomas, which have not yet been described in NFI, cutaneous schwannomas, spinal schwannomas, lack of Lisch nodules (with a few exceptions), fewer CALs, and the presence of juvenile onset cataracts. The comparative features are outlined in Table 3 . Patients with NF2 tend to develop tumours ofthe neural coverings or linings, such as meningiomas, optic nerve sheath meningiomas, schwannomas, and ependymomas, whereas those with NFl tend to develop neural or astrocytic tumours (astrocytomas, gliomas, and optic nerve gliomas). The reason for this is obscure at present.
Clinicalfeatures
As in NFI, there is huge variability in expression of the disease phenotype between individuals with NF2, both in terms of tumour type and location and the clinical severity of disease."2 However, in contrast to NFI, much of this variability is interfamilial rather than intrafamilial, suggesting that particular mutations within the NF2 gene may be important in determining severity. It has been suggested that within the clinical spectrum of NF2, there may be certain disease phenotypes that breed true within families."' 1"14 The types are:
(1) Wishart 7 Although these phenotypes may eventually be confirmed by specific sites of genetic mutation within the NF2 gene, modern imaging techniques and genetic testing suggest a far greater variability in disease expression and many individuals cannot be classified readily into a particular group." ' 118 Individuals with NF2 most commonly present with hearing loss, sometimes with concomitant tinnitus or unsteadiness. The average age of onset of hearing loss in NF2 is in the teens or twenties; however it is possible to present as early as the first or as late as the seventh decade."9 In one study, the presenting symptoms were most commonly bilateral hearing loss (50% of individuals), then unilateral hearing loss (21%), followed by imbalance or vestibular disturbance (10%) and tinnitus (9%).108 Headache, visual symptoms, facial paresis or other neurological symptoms accounted for about 10% of initial presentations. This pattern of presentation may change with increased awareness of the disease by the medical profession.
Schwann cell tumours of the central nervous system are the commonest type of tumour and include vestibular schwannomas (a more accurate term than acoustic neuroma), cranial nerve and spinal root schwannomas, and intramedullary schwannomas. Other tumours including multiple meningiomas, optic nerve sheath meningiomas, and gliomas are also common in NF2. Although the latter are of low histological grade, they can cause devastating disease if located in the brain stem or spinal cord. Deep plexiform neurofibromas demonstrate behaviour similar to those of NF1, leading to neurological dysfunction and possible malignant degeneration.
Dermatological signs of NF2 tend to be less profuse and are less often a presenting feature than in NFI. The skin signs, which overlap with NFl, include typical cafe au lait patches, which tend to be few in number, atypical areas of hyperpigmentation with indistinct borders, hypopigmented macules, hairy naevus, cutaneous neurofibromas, usually fewer than in NFl, and deep plexiform neurofibromas. However, more specific signs of NF2 include cutaneous schwannomas, which are harder than the more fleshy neurofibromas and have a rougher surface, subcutaneous schwannomas, which may be located in the spinal region (Fig 6) , and neurofibromas in special locations -for example, nasolabial fold, palmar (V M Riccardi, personal communication).
Ocular manifestations
Recent observations suggest an extremely high prevalence of ocular findings in NF2. More than 75% of patients with NF2 are known to have premature loss of vision due to posterior subcapsular lens opacities.120"2' These opacities are rarely congenital, but are more often acquired in childhood or early adult life. Although posterior capsular or subcapsular cataracts were the first type to be described, it is clear that juvenile onset cortical cataracts can also be associated (Fig 7) .121 122 Optic nerve sheath meningiomas are also a well described association with NF2 and can lead to progressive visual loss (Fig 8) .l22 123 Recently, isolated' 125-127 and familial'2" cases of combined 668 group.bmj.com on July 6, 2017 -Published by http://bjo.bmj.com/ Downloaded from regular magnetic resonance imaging with gadolinium for the assessment of vestibular schwannomas, and other central nervous system tumours, and spinal tumours."9 In the absence of tumours -for example, vestibular schwannomas, these scans should be performed annually (Fig 9) 11.2.110 '35-'4°The NF2 gene locus was further narrowed down to a region between the markers D22S1 and D22S28 by tumour deletion studies (Fig 10) in meningiomas and vestibular schwannomas and family studies in a similar fashion to retinoblastoma.'4' It was assumed that the same genetic locus was responsible for both the sporadic tumours of the type seen in NF2 -for example, meningiomas, vestibular schwannomas, ependymomas, and NF2 itself. If Knudson's two hit hypothesis applied and one copy of the gene was lost in tumour formation, determination of the common area deleted in the tumours would lead to the position of the NF2 gene. Tumour tissue studies on both meningiomas and vestibular schwannomas demonstrated a loss of one chromosome 22 allele, corresponding to loss of the normal second copy (the 'second hit'). Until recently it was observed that entire chromosome copies were lost, but then partial losses were seen and this led to an advance in the mapping of the NF2 gene.
More recently a candidate for the NF2 gene has been found.'42-'" The gene encodes a 587 amino acid protein and has been provisionally named 'merlin' because of its resemblance to moesin, ezrin, and radixin, three members of a family ofproteins that link cytoskeletal components with cell membrane proteins.'42 Merlin, also called 'schwannomin','43" is a novel type of tumour or growth suppressor protein. Mutations in such a protein could affect any number of cellular processes, including cell division, cell-cell communication, intracellular arrangement, shape, movement, or anchorage. [142] [143] [144] There are many parallels that can be drawn between the tumour formation in retinoblastoma and that in NF2.7980 The sporadic tumours in both diseases, using vestibular schwannomas as the example, develop at a later age and occur unilaterally. In the inherited form, not only does bilateral disease occur earlier, but also other tumour types may develop. It appears that individuals with a mutation at the NF2 locus are predisposed to develop multiple tumour types depending on the tissue that develops a second mutation. This supposes that in a similar way to retinoblastoma one normal copy of the NF2 gene is enough to regulate cell growth. When the second mutation occurs, the cell is able to proliferate in an uncontrolled fashion.
Ofspecial interest in NF2 are the developmental anomalies that can occur in the eye including the retinal hamartomas and cataract. Further characterisation of merlin schwannomin may help to explain why such developmental anomalies occur with single copy germline mutations in the NF2 gene and tumours develop with loss of both copies.
Other genetic influences Gene modification by imprinting could be important in NF2. This was suggested by both an earlier age of onset and death when the disease was inherited through the mother.'08". However, social circumstances, such as increased likelihood that an affected mother would take her child for screening, may be confounding factors."°" ' A preponderance of maternally inherited cases was also noted in one study, but this may be related to reduced paternal fitness in males and non-paternity among sporadic cases."' The sex of the patient did not, however, affect the age at onset, except perhaps in the case of men with the Feiling-Gardner phenotype when the progression may be very slow. SUMMARY NF2 is a rare, dominantly inherited condition that leads to multiple tumour formation throughout the central nervous system and ocular abnormalities. It has been mapped to chromosome 22. The NF2 gene may be a new type of tumour
